(Z)-Endoxifen for the Treatment of Premenopausal Women With ER+/HER2- Breast Cancer
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Matthew P Goetz, MD
Mayo Clinic
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Mayo Clinic Arizona
Phoenix, Arizona, United States
- University of Arizona
Tucson, Arizona, United States
- California Research Institute
Los Angeles, California, United States
- Mayo Clinic Florida
Jacksonville, Florida, United States
- Northwestern University
Chicago, Illinois, United States
- St. Elizabeth Healthcare
Edgewood, Kentucky, United States
- Henry Ford Cancer Institute
Detroit, Michigan, United States
- Mayo Clinic Rochester
Rochester, Minnesota, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Avera Cancer Institute
Sioux Falls, South Dakota, United States
- Vanderbilt Ingram Cancer Center
Nashville, Tennessee, United States
- Baylor University
Houston, Texas, United States
- Bon Secours Cancer Institute
Midlothian, Virginia, United States
- Fred Hutchinson Cancer Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 14 Feb 2023
- Primary completion
- 30 Nov 2026
- Completion
- 30 Apr 2027
- Last update posted
- 8 Jul 2026
- Registered enrollment
- 87
- Registry id
- NCT05607004
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.